Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction

Chinese Medical Journal

Volumn 120, Issue 14, 2007, Pages 1226-1231

  Fu, Xiang Hua ^a   Fan, Wei Ze ^a   Gu, Xin Shun ^a   Wei, Yong Yun ^a   Jiang, Yun Fa ^a   Wu, Wei Li ^a   Li, Shi Qiang ^a   Hao, Guo Zhen ^a   Wei, Qing Min ^a   Xue, Ling ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Anisodamine; Myocardial infarction; Percutaneous coronary intervention; Slow reflow phenomenon

Indexed keywords

ANISODAMINE; GLYCERYL TRINITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY SPASM; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART MUSCLE PERFUSION; HEART RATE; HEART VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PR INTERVAL; QRS COMPLEX; QT INTERVAL; QUANTITATIVE ANALYSIS; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; TIME; TREATMENT OUTCOME;

EID: 34547750365     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200707020-00004     Document Type: Article

References (30)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic: therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
2. Grines CL, Westerhausen DR Jr, Grines LL, Hanlon JT, Logemann TL, Niemela M, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 2002; 39: 1713-1719.
3. Morishima I, Sone T, Okumura Y, Tsubo H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000; 36: 1202-1209.
4. Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 2003; 145: 42-46.
5. Kotani JI, Nanto S, Mintz GS, Kitakaze M, Ohara T, Morozumi T, et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002; 106: 1672-1677.
6. Kaufmann PA, Carnici PG. Myocardial blood flow by PET: technical aspects and clinical applications. J Nucl Med 2005; 46: 75-88.
7. Agati L, Tonti G, Galiuto L, Di Bello V, Funaro S, Madanna MP, et al. Quantification methods in contrast echocardiography. Eur J Echocardiogr 2005; 6 Suppl 2: S14-S20.
8. Lepper W, Hoffmann R, Kamp O, Franke A, de Cock CC, Kühl HP, et al. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angiography in patients with acute myocardial infarction. Circulation 2000; 101: 2368-2374.
9. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002; 105: 656-662.
10. Camici PG, Crea IF. Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830-840.
11. Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000; 101: 2154-2159.
12. Assali AR, Sdringola S, Ghani M, Denkats AE, Yepes A, Hanna GP, et al. Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon. Catheter Cardivasc Inerv 2000; 51: 27-31.
13. Lim SY, Bae EH, Jeong MH, Kang DG, Lee YS, Kim KH, et al. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention. Circulation 2004; 68: 928-932.
14. Hang CL, Wang CP, Yip HK, Yang CH, Guo GB, Wu CJ, et al. Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction. Chest 2005; 128: 2593-2598.
15. Fu XH, Li XH, Wu WL, Gu XS, Ma N, Li SQ, et al. Effect of intracoronary administration of diltiazem on slow-reflow phenomenon following primary PTCA in patients with AMI. Chin J Cardiol (Chin) 2001; 29: 732-735.
16. Xiu RJ, Hammerschmidt DE, Coppo PA, Jacob HS. Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock. JAMA 1982; 247: 1458-1460.
17. Xiu RJ. Microcirculation-the subtle life wellspring. J Microcirculation (Chin) 1997; 7: 1-3.
18. Fu XH, Liu XK, Gu XS, Fan WZ, Hao GZ, Liu J, et al. Establishing chronic heart failure model in miniswine with injection of plastic microspheres by a 4F angiographic catheter of superselective engaging in LAD. Natl Med J China (Chin) 2006; 86: 1129-1132.
19. Fu XH, Gu XS, Fan WZ, Wei YY, Hao GZ, Jiang YF, et al. Effect of intracoronary anisodamine on no-reflow phenomenon after PCI in mini-pig with AMI. Circulation 2006; 114: II-511.
20. Fu XH, Gu XS, Fan WZ, Jiang YF, Wu WL, Li SQ, et al. Protective effects of anisodamine on the myocardial experienced ischemia-reperfusion in minipigs. Clin Cardiol 2006; 29 Suppl IV: 169-170.
21. Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander JB, Marble SJ, et al. TIMI fimne count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-888.
22. Hoffmann R, Haager P, Arning J, Christott P, Radke P, Blindt R, et al. Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction predicting left ventricular function. Am J Cardiol 2003; 92: 1015-1019.
23. Gibson CM, Cannon CA, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TTMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125-130.
24. Henriques JP, Zijlstra F, Ottrvanger JP, de Boer MJ, van't Hof AW, Hoorntje JC, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112-1117.
25. Xiu RJ. Observations on the calibre changes of microvessels in golden hamster by a CCTV system. Natl Med J China (Chin) 1981; 61: 270-273.
26. Xiu RJ, Intaglietta M. Microvascular vasomotion: I. Long-term observation and computer analysis of the vasomotion. Natl Med J China (Chin) 1985; 65: 129-135.
27. Yu CH, Xu KL, Liu ZB. The change of the transmogrification ability of leukocyte in acute ischemia-reperfusion rabbit and the influence of anisodamine. J Qingdao Med College (Chin) 1998; 29:188-190.
28. Reffelmann T, Hale SL, Dow JS, Moner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 2003; 108: 2911-2917.
29. Matsumoto H, Inoue N, Takaoka H, Hata, K, Shinke T, Yoshikawa R. Depletion of antioxidants is associated with no-reflow phenomenon in acute myocardial infarction. Clin Cardiol 2004; 27: 466-470.
30. Zalewski J, Zmudka Y, Musialek P, Zajdel W, Pieniazek P, Kadzielski A, et al. Detection of microvascular injury by evaluating epicardial blood flow in early reperfusion following primary angioplasty. Int J Cardiol 2004; 389-396.